HC Wainwright restated their buy rating on shares of Merus Labs International (TSE:MSL – Free Report) (NASDAQ:MSLI) in a research report report published on Monday morning, Zacks.com reports. HC Wainwright also issued estimates for Merus Labs International’s Q1 2024 earnings at ($0.05) EPS, Q2 2024 earnings at ($0.05) EPS, Q3 2024 earnings at ($0.05) EPS, Q4 2024 earnings at ($0.05) EPS, FY2024 earnings at ($0.19) EPS, Q1 2025 earnings at ($0.05) EPS, Q2 2025 earnings at ($0.05) EPS, Q3 2025 earnings at ($0.05) EPS, Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.20) EPS, FY2026 earnings at ($0.18) EPS, FY2027 earnings at ($0.23) EPS and FY2028 earnings at ($0.22) EPS.
Merus Labs International Stock Performance
The company’s 50-day moving average price is C$1.65. Merus Labs International has a one year low of C$0.95 and a one year high of C$1.76.
Merus Labs International (TSE:MSL – Get Free Report) (NASDAQ:MSLI) last issued its quarterly earnings results on Wednesday, March 27th. The specialty pharmaceutical company reported C($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.01) by C($0.05).
Merus Labs International Company Profile
Merus Labs International Inc is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company’s products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin.
Featured Stories
- Five stocks we like better than Merus Labs International
- How is Compound Interest Calculated?
- United Airlines Soars on Earnings Beat
- Where Do I Find 52-Week Highs and Lows?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Merus Labs International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus Labs International and related companies with MarketBeat.com's FREE daily email newsletter.